Government nod to 6-month therapy for drug-resistant TB | India News – Times of India

NEW DELHI: The health ministry on Friday approved the introduction of the BPaLM regimen – a novel treatment for Multidrug-Resistant Tuberculosis (MDR-TB) – under its National TB Elimination Program (NTEP).While traditional MDR-TB treatments can last up to 20 months with severe side effects, BPaLM regimen can cure the drug-resistant TB in just six months with…

Read More

No pricks: Oral TB drug for under 5 gets nod | India News – Times of India

MUMBAI: In the battle against drug-resistant tuberculosis (TB), young children have faced a particularly challenging hurdle: the painful injectables in treatment regimens. These medications, notorious for their severe side effects, added an extra layer of distress to an already daunting ordeal for infants and children. Now, with approval of Delamanid for children under 5 in…

Read More